Skip to main content

"A multiple patient early access program for olaparib tablets for the maintenance treatment following response (complete response or partial response) to platinum-based chemotherapy in patients with platinumsensitive relapsed high-grade epithelial ov

Clinical Trial Grant
Duke Scholars

Administered By

Duke Cancer Institute

Awarded By

AstraZeneca AB

Start Date

July 12, 2017

End Date

July 30, 2018
 

Administered By

Duke Cancer Institute

Awarded By

AstraZeneca AB

Start Date

July 12, 2017

End Date

July 30, 2018